Embryonal Tumor With Multilayered Rosettes

Undergo RT

One or more of the following may be assigned by the physician (physician's choice) per standard of care guidelines upon study enrollment following surgery: Cytarabine, Carboplatin, Cisplatin, Vincristine Sulfate injection (Vincristine PFS), Topotecan Hydrochloride, Dactinomycin, Thiotepa, Filgrastim, Cyclophosphamide, or Doxorubicin Hydrochloride. Not all participants will receive all possible drug regimens.

Undergo surgery directly before study enrollment as part of planned care.

Participants assigned to or whom receive optional RT will receive concurrent temozolomide

Tumor tissue will be collected for correlative studies

Blood samples will be collected for correlative studies

CSF samples will be collected for correlative studies